1607 Capital Partners, LLC Tekla Life Sciences Investors Transaction History

1607 Capital Partners, LLC

$1.24 Billion
Q4 2024

A detailed history of 1607 Capital Partners, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, 1607 Capital Partners, LLC holds 247,147 shares of HQL stock, worth $3.42 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

247,147

Previous 349,501 29.29%

Holding current value

$3.42 Million

Previous $5.27 Million 38.48%

% of portfolio

0.26%

Previous 0.48%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$13.12 - $15.25 $1.34 Million - $1.56 Million	-102,354 Reduced 29.29%	247,147 $3.24 Million
Q3 2024 Nov 14, 2024	SELL	$14.26 - $15.78 $995,034 - $1.1 Million	-69,778 Reduced 16.64%	349,501 $5.27 Million
Q2 2024 Aug 08, 2024	SELL	$12.79 - $14.27 $794,259 - $886,167	-62,100 Reduced 12.9%	419,279 $5.94 Million
Q1 2024 May 13, 2024	BUY	$13.38 - $14.33 $16,056 - $17,196	1,200 Added 0.25%	481,379 $6.56 Million
Q4 2023 Feb 13, 2024	BUY	$11.35 - $13.6 $8,671 - $10,390	764 Added 0.16%	480,179 $6.46 Million
Q2 2023 Aug 14, 2023	BUY	$13.13 - $14.17 $206,141 - $222,469	15,700 Added 3.39%	479,415 $6.49 Million
Q1 2023 May 15, 2023	BUY	$13.37 - $14.94 $989,166 - $1.11 Million	73,984 Added 18.98%	463,715 $6.46 Million
Q4 2022 Feb 14, 2023	BUY	$13.55 - $15.23 $4.13 Million - $4.64 Million	304,830 Added 359.04%	389,731 $5.54 Million
Q3 2022 Nov 14, 2022	BUY	$13.39 - $16.31 $1.14 Million - $1.38 Million	84,901 New	84,901 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$18.5 - $21.59 $185,000 - $215,900	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.27 - $22.67 $2.05 Million - $2.29 Million	-100,901 Reduced 90.98%	10,000 $208,000
Q2 2021 Aug 16, 2021	SELL	$19.14 - $21.44 $934,835 - $1.05 Million	-48,842 Reduced 30.58%	110,901 $2.38 Million
Q1 2021 May 17, 2021	SELL	$19.31 - $22.07 $835,060 - $954,417	-43,245 Reduced 21.3%	159,743 $3.15 Million
Q3 2020 Nov 16, 2020	BUY	$16.71 - $19.06 $467,278 - $532,993	27,964 Added 15.98%	202,988 $3.57 Million
Q2 2020 Aug 14, 2020	BUY	$14.22 - $18.38 $1.44 Million - $1.87 Million	101,513 Added 138.09%	175,024 $3.14 Million
Q1 2020 May 15, 2020	BUY	$12.22 - $17.99 $898,304 - $1.32 Million	73,511 New	73,511 $1.1 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.65M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1607 Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1607 Capital Partners, LLC with notifications on news.

Account

1607 Capital Partners, LLC Tekla Life Sciences Investors Transaction History